NYSE: AZNAstrazeneca PLC Stock Ownership - Who owns Astrazeneca?
Insider buying vs selling
Have Astrazeneca PLC insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Mani Sharma | SVP Group Controller and Head of Global Finance Services | 2026-07-06 | 2 | $190.43 | $380.86Buy |
| Mani Sharma | SVP Group Controller and Head of Global Finance Services | 2026-06-08 | 1 | $179.75 | $179.75Buy |
| Mani Sharma | SVP Group Controller and Head of Global Finance Services | 2026-05-20 | 11,893 | $185.78 | $2.21MSell |
| Mani Sharma | SVP Group Controller and Head of Global Finance Services | 2026-05-06 | 1 | $186.28 | $186.28Buy |
| Mani Sharma | SVP Group Controller and Head of Global Finance Services | 2026-04-07 | 1 | $196.03 | $196.03Buy |
AZN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when AZN insiders and whales buy or sell their stock.
AZN Shareholders
What type of owners hold Astrazeneca PLC stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Investor Ab | 3.33% | 51,587,810 | $8.75B | Institution |
| Vanguard Capital Management LLC | 2.91% | 45,040,142 | $7.64B | Institution |
| Capital International Investors | 2.22% | 34,393,013 | $5.83B | Institution |
| Fmr LLC | 1.91% | 29,601,724 | $5.02B | Institution |
| Capital World Investors | 1.82% | 28,264,580 | $4.79B | Institution |
| Legal General Group PLC | 1.67% | 25,849,978 | $4.39B | Institution |
| Wellington Management Group LLP | 1.53% | 23,751,085 | $4.03B | Institution |
| Price T Rowe Associates Inc | 1.26% | 19,489,220 | $3.31B | Institution |
| Bank Of America Corp | 1.23% | 19,058,327 | $3.23B | Institution |
| Jpmorgan Chase Co | 1.20% | 18,590,922 | $3.15B | Institution |
AZN vs General Drug Manufacturer Stocks
Astrazeneca Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.